Klotho: The Longevity Protein, Explained

Klotho got its name from one of the Fates, the one who spins the thread of life. That is a heavy expectation to place on a single protein, and the science is more measured than the mythology. Still, klotho is one of the more interesting molecules in aging research, largely because the early mouse findings were genuinely striking.

Why researchers pay attention

The interest began in 1997, when Makoto Kuro-o and colleagues reported in Nature that mice with a defect in the klotho gene developed “a syndrome that resembles human ageing, including a short lifespan, infertility, arteriosclerosis, skin atrophy, osteoporosis and emphysema.” That a single gene defect could produce such a broad aging-like picture put the protein on the map.

The other half of the story came in 2005, when Kurosu and colleagues showed in Science that overexpressing klotho extended lifespan in mice — and that klotho acts as a circulating hormone that suppresses insulin and IGF-1 signaling, an evolutionarily conserved longevity pathway.

Mouse group (Kurosu 2005, Science)	Median male lifespan	Median female lifespan
Wild-type	715 ± 44 days	697 ± 45 days
Klotho-overexpressing (EFmKL46)	858 ± 40 days	829 ± 32 days
Klotho-overexpressing (EFmKL48)	936 ± 47 days	830 ± 29 days

Klotho has since been linked to kidney function, mineral metabolism, and cognition. In a 2014 Cell Reports study, Dubal and colleagues found that the longevity-associated KL-VS genetic variant was associated with better cognition — but notably only in heterozygous carriers (one copy), across three populations and all ages examined, not in people carrying two copies.

The animal data are striking and the human associations are intriguing, but a clear path from those findings to a safe, effective klotho-boosting intervention in people does not yet exist.

What we do and don’t know

Reasonably established

• Klotho is a real, biologically important protein; in mice, manipulating it changes lifespan and aging-related traits.
• Its levels tend to decline with age, and the KL-VS heterozygous genotype associates with better cognition in humans.
• Exercise raises circulating klotho. A 2022 Scientific Reports meta-analysis (12 reports, 621 participants) found chronic training — minimum ~12 weeks — significantly increased soluble klotho (Hedges’ g 1.3; 95% CI 0.69–1.90).

Still open

• Whether raising klotho in people improves aging outcomes or cognition.
• How to raise it safely and durably for longevity. Exercise nudges levels, but the longevity relevance of that bump is unproven.
• Whether klotho-based therapeutics translate. There is no FDA-approved klotho drug; investigational candidates remain in early human trials.

The gap between “this protein matters in biology” and “boosting it helps people live or think better” is exactly where a lot of longevity hype lives.

The takeaway

Klotho is a legitimately fascinating protein with strong animal data and suggestive human associations, particularly around cognition. That is why serious labs study it. It is also, today, a research story rather than a recommendation. There is no validated way to meaningfully and safely raise klotho for longevity, and anything sold on that promise is running well ahead of the evidence. Worth watching, not yet worth acting on.

Sources

• Mutation of the mouse klotho gene leads to a syndrome resembling ageing (Kuro-o et al., Nature 1997)
• Suppression of aging in mice by the hormone Klotho (Kurosu et al., Science 2005)
• Life Extension Factor Klotho Enhances Cognition (Dubal et al., Cell Reports 2014)
• Klotho as an emerging exerkine: a systematic review and meta-analysis (Scientific Reports 2022)